Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Up 2.9% – Should You Buy?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) shares shot up 2.9% on Tuesday . The stock traded as high as $26.00 and last traded at $25.82. 10,201 shares traded hands during trading, a decline of 96% from the average session volume of 271,970 shares. The stock had previously closed at $25.10.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on KMTS shares. Wall Street Zen downgraded shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, September 28th. BTIG Research began coverage on shares of Kestra Medical Technologies in a research note on Tuesday. They set a “buy” rating and a $32.00 price target for the company. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Kestra Medical Technologies in a research note on Wednesday, October 8th. Six analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.00.

Kestra Medical Technologies Price Performance

The firm has a market cap of $1.36 billion and a P/E ratio of -10.33. The business’s fifty day simple moving average is $24.66 and its 200-day simple moving average is $20.45. The company has a current ratio of 6.84, a quick ratio of 6.84 and a debt-to-equity ratio of 0.23.

Kestra Medical Technologies (NASDAQ:KMTS) last announced its quarterly earnings results on Thursday, September 11th. The company reported ($0.50) earnings per share for the quarter, beating the consensus estimate of ($0.66) by $0.16. The company had revenue of $19.37 million during the quarter, compared to analysts’ expectations of $17.68 million. Kestra Medical Technologies has set its FY 2026 guidance at EPS.

Hedge Funds Weigh In On Kestra Medical Technologies

Several hedge funds have recently bought and sold shares of KMTS. Quarry LP purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $33,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Kestra Medical Technologies during the 3rd quarter valued at about $48,000. BNP Paribas Financial Markets lifted its holdings in shares of Kestra Medical Technologies by 148.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company’s stock worth $65,000 after acquiring an additional 1,638 shares during the last quarter. Brown Brothers Harriman & Co. grew its position in Kestra Medical Technologies by 26.8% in the third quarter. Brown Brothers Harriman & Co. now owns 3,104 shares of the company’s stock worth $74,000 after acquiring an additional 656 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey bought a new position in Kestra Medical Technologies in the second quarter valued at $54,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.